ESC 365 - Risk stratification in primary and secondary prevention: What is the value of the cardiac biomarkers?

EAPC Premium Access

Risk stratification in primary and secondary prevention: What is the value of the cardiac biomarkers?

Session: Emerging role of cardiac biomarkers in cardiovascular risk stratification

Topic: Biomarkers

Speaker: Doctor A. Shah (London, GB)

Sponsored by Abbott

Event: ESC Preventive Cardiology 2021

Congress Presentation

Add to my library

About the speaker

Doctor Anoop Shah

London School of Hygiene and Tropical Medicine, London (United Kingdom of Great Britain & Northern Ireland)

3 presentations

0 follower

4 more presentations in this session

Welcome & Introduction.

Speaker: Professor W. Koenig (Munich, DE)

Cardiovascular risk prediction models: Translating statistics into clinical practice.

Speaker: Doctor L. Leite (Coimbra, PT)

Panel discussion: Advancing cardiovascular risk assessment with high-sensitivity troponin I.

Summary and closing remarks.

Speaker: Professor W. Koenig (Munich, DE)

Access the full session

Emerging role of cardiac biomarkers in cardiovascular risk stratification

Speakers: Doctor A. Shah, Professor W. Koenig, Doctor L. Leite, Professor W. Koenig

About the event

ESC Preventive Cardiology 2021

15 April - 17 April 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources